Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Mar;188(3):836-846.
doi: 10.1002/ajmg.a.62592. Epub 2021 Dec 10.

Giant axonal neuropathy (GAN) in an 8-year-old girl caused by a homozygous pathogenic splicing variant in GAN gene

Affiliations
Case Reports

Giant axonal neuropathy (GAN) in an 8-year-old girl caused by a homozygous pathogenic splicing variant in GAN gene

Yufan Guo et al. Am J Med Genet A. 2022 Mar.

Abstract

Giant axonal neuropathy (GAN) is a progressive disease that involves the peripheral and central nervous systems. This neurodegenerative disease is caused by variants in the GAN gene encoding gigaxonin, and is inherited in an autosomal recessive manner. Herein, we performed whole-exome sequencing on a 8-year-old child with dense, curly hair, weakness in both lower limbs, and abnormal MRI. The child was born to consanguineous parents. Our results revealed that the child carried the c.1373+1G>A homozygous pathogenic variant of the GAN gene, while both parents were heterozygous carriers. According to the validation at the cDNA levels, the splicing variant led to the skipping of exon 8 and affected the Kelch domain's formation. Unlike the previously reported cases of GAN, the child's clinical manifestations revealed peripheral nervous system involvement, no vertebral signs, cerebellar signs, and spasticity, but only MRI abnormalities. These results suggested that the patient's central nervous system was mildly involved, which may be related to the genotype. In order to further clarify the correlation between GAN genotype and phenotype, combined with this patient, 54 cases of reported homozygous variants of the GAN gene were merged for the analysis of genotype and phenotype. The results revealed a certain correlation between the GAN gene variant domain and the patient's clinical phenotype, such as central nervous system involvement and age of onset.

Keywords: central nervous systems; genotype; giant axonal neuropathy; peripheral nervous systems; phenotype.

PubMed Disclaimer

References

REFERENCES

    1. Abu-Rashid, M., Mahajnah, M., Jaber, L., Kornreich, L., Bar-On, E., Basel-Vanagaite, L., Soffer, D., Koenig, M., & Straussberg, R. (2013). A novel mutation in the GAN gene causes an intermediate form of giant axonal neuropathy in an Arab-Israeli family. European Journal of Paediatric Neurology, 17(3), 259-264. https://doi.org/10.1016/j.ejpn.2012.10.012
    1. Aharoni, S., Barwick, K. E., Straussberg, R., Harlalka, G. V., Nevo, Y., Chioza, B. A., McEntagart, M. M., Mimouni-Bloch, A., Weedon, M., & Crosby, A. H. (2016). Novel homozygous missense variant in GAN associated with CharcotMarie-Tooth disease type 2 in a large consanguineous family from Israel. BMC Medical Genetics, 17, 82.
    1. Allen, E., Ding, J., Wang, W., Pramanik, S., Chou, J., Yau, V., & Yang, Y. (2005). Gigaxonin-controlled degradation of MAP1B light chain is critical to neuronal survival. Nature, 438(7065), 224-228.
    1. Bacquet, J., Stojkovic, T., Boyer, A., Martini, N., Audic, F., Chabrol, B., Salort-Campana, E., Delmont, E., Desvignes, J. P., Verschueren, A., Attarian, S., Chaussenot, A., Delague, V., Levy, N., & Bonello-Palot, N. (2018). Molecular diagnosis of inherited peripheral neuropathies by targeted next-generation sequencing: Molecular spectrum delineation. BMJ Open, 8, e021632.
    1. Boizot, A., Talmat-Amar, Y., Morrogh, D., Kuntz, N. L., Halbert, C., Chabrol, B., Houlden, H., Stojkovic, T., Schulman, B. A., Rautenstrauss, B., & Bomont, P. (2014). The instability of the BTB-KELCH protein Gigaxonin causes Giant Axonal Neuropathy and constitutes a new penetrant and specific diagnostic test. Acta Neuropathologica Communications, 2(1), https://doi.org/10.1186/2051-5960-2-47

Publication types

Substances

LinkOut - more resources